Catherine Debras Schloesing
About Catherine Debras Schloesing
Catherine Debras Schloesing serves as the Directrice R&D at Laboratoire Aguettant, where she has worked since 2017. With a background in pharmaceutical development and a strong focus on industrialization processes, she oversees a team of 40 and has played a significant role in implementing Medical Device Regulation for combination products.
Current Role at Laboratoire Aguettant
Catherine Debras Schloesing serves as the Directrice R&D at Laboratoire Aguettant, a position she has held since 2017. In this role, she oversees a team of 40 professionals, including managers, executives, and technicians. Her responsibilities include leading the research and development initiatives within the organization and ensuring the successful transfer of projects from R&D to industrial production.
Previous Experience at Laboratoire Aguettant
Before her current position, Catherine worked at Laboratoire Aguettant in various roles. She was the chef de projet développement pharmaceutique for 11 months in 2014, followed by a two-year tenure as Responsable Transfert Produit from 2015 to 2017. Additionally, she served as Responsable d'Etudes R&D from 2011 to 2014, contributing to the company's research and development efforts.
Education and Certifications
Catherine has a strong educational background. She studied at the Ecole Nationale Supérieure de Chimie de Montpellier, earning a degree in Chimie Biologie Santé from 2002 to 2005. She furthered her education at Polytechnique, obtaining a Certification Stratège de la transformation from 2021 to 2022. Additionally, she completed a Programme d'accompagnement pour profil à haut potentiel at Ecole de Management de la Sorbonne, achieving a Certification Management d'entreprise from 2015 to 2016.
Professional Background in Pharmaceutical Development
Catherine has extensive experience in pharmaceutical development. She worked at Unither Pharmaceuticals as Ingénieur Développement from 2006 to 2011 and was a stagiaire ingénieur développement at Sanofi Pasteur in 2006. Her expertise includes the industrialization process and the implementation of Medical Device Regulation (MDR) for combination products, such as pre-filled syringes.
Leadership and Project Management
In her role as Directrice R&D, Catherine has played a significant role in leading major change control processes and overseeing new industrial investments since 2018. She was also a key member of the operational committee from 2019 to 2021, focusing on project identification and tracking across various departments, including Quality Assurance, Industry, Supply, Regulatory Affairs, and Support.